Tissue-engineered cartilage repair for knee cartilage defects
Official title: Clinical Study of Cartilage Constructed by Autologous Bone Marrow Mesenchymal Stem Cells in Repairing Articular Cartilage Defects
Run by The First Affiliated Hospital of Xinxiang Medical College · NCT07094100 · Data updated 2026-11-12
This trial will try tissue-engineered cartilage made from a patient's own bone marrow stem cells to repair cartilage defects in adults with knee injuries or osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | The First Affiliated Hospital of Xinxiang Medical College Academic / other |
| Locations | 1 site (Xinxiang, Henan) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07094100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with mature growth plates who have up to four focal cartilage defects on the distal weight-bearing femoral condyle, intact cruciate ligaments, and willingness to follow the postoperative rehabilitation program are ideal candidates.
✕Probably not a fit
Patients with BMI over 35, significant lower-limb malalignment (valgus >10° or varus >5°), multiple ligament injuries, heavy smoking/drug/alcohol use, or recent open knee surgery are unlikely to receive benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The intervention uses autologous bone marrow mesenchymal stem cells expanded in vitro and combined with a three-dimensional scaffold to create living cartilage for implantation. The engineered tissue is implanted into focal defects on the distal weight-bearing surface of the femoral condyle of the knee. Eligible adults (18–65) with up to four localized lesions and intact cruciate ligaments undergo surgery and a strict postoperative rehabilitation program with planned clinical follow-up. Outcomes will include measures of cartilage repair, joint function, and safety over the follow-up period.
Why it matters
Potential benefit: If successful, this approach could restore damaged cartilage, improve knee function, and slow progression to osteoarthritis, potentially reducing the need for more invasive surgeries.
How similar studies have gone: Laboratory and early clinical work indicates BMSC-based tissue-engineered cartilage can form cartilage-like tissue, but large-scale clinical success and long-term superiority over standard treatments remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The patients' age ranges from 18 to 65 years old, and gender is not restricted; 2. The imaging results show that the epiphyseal growth is mature; 3. The defects or localized injuries of joint cartilage caused by trauma or other reasons; 4. The injured area is the distal weight-bearing surface of the femoral condyle of the knee joint, with no more than 4 lesions, and there is no injury to the cruciate ligaments; 5. The patients voluntarily sign and provide a written informed consent form and are willing to closely cooperate with the doctor's strict postoperative rehabilitation program. Exclusion Criteria: 1. The patient is extremely overweight, with a body mass index greater than 35; 2. The lower limb alignment is valgus by more than 10° and varus by more than 5°; 3. Multiple ligament injuries; 4. There are numerous bad habits such as heavy smoking, drug abuse, and excessive alcohol consumption; 5. Has undergone open knee joint surgery within the past six months; 6. Has severe joint stiffness or fibrosis; 7. Has an allergic constitution or a history of allergic reactions to collagen; 8. Has mental abnormalities; 9. Cannot or is unwilling to undergo rehabilitation training; 10. Has primary cardiovascular diseases, lung diseases, endocrine and metabolic disorders, or other serious diseases that affect their daily life, such as tumors or AIDS; 11. Pregnant or lactating women, or those planning to conceive during the trial period; 12. Other acute or chronic diseases, for which the researchers consider surgery to be inappropriate.
Where it's running
-
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China Recruiting
Study contacts
- Study coordinator: Wenjie Ren
- Email: 13937354075@163.com
- Phone: 8613937354075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating PRP injections for knee osteoarthritis treatment
This study is testing whether platelet-rich plasma (PRP) injections can help people with knee osteoarthritis and related injuries feel better.
-
Multi-omics view of androgenetic alopecia in scalp tissue
This study tests a multi-omics approach to understand hair follicle biology in men with androgenetic alopecia by comparing affected and healthy scalp tissue.
-
Mesenchymal stem cell gel for improving healing of burn skin grafts
This study will test whether applying a low- or high-dose mesenchymal stem cell gel to donor skin sites helps them heal faster and with better outcomes after autologous skin grafting in adult burn patients.
-
Biomarker screening to detect early femoral head osteonecrosis
This project will test whether blood biomarkers can help detect osteonecrosis of the femoral head earlier in adults who are suspected to have the condition.
-
Screening blood biomarkers for osteoarthritis diagnosis
This project will test whether certain blood biomarkers can help diagnose osteoarthritis in people aged 40–70 who have had joint pain or stiffness for at least three months.
-
Human umbilical cord mesenchymal stem cells with bovine type I collagen for third-degree burn wounds
This will test whether human umbilical cord mesenchymal stem cells combined with bovine type I collagen are safe and tolerable for adults with small third-degree burn wounds.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.